Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study.

Autor: Decker B; Institute of Health Economics and Technology Assessment, Prague, Czech Republic.; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Tuzil J; Institute of Health Economics and Technology Assessment, Prague, Czech Republic.; Department of Medical Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic., Lukas M; IBD clinical and research center ISCARE a.s, Prague, Czech Republic.; Institute of Medical Biochemistry and Laboratory Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic., Cerna K; IBD clinical and research center ISCARE a.s, Prague, Czech Republic., Bortlik M; Gastroenterology Department, Ceske Budejovice Hospital, Ceske Budejovice, Czech Republic.; Department of Internal Medicine, Military University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.; Institute of Pharmacology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Velackova B; Institute of Health Economics and Technology Assessment, Prague, Czech Republic., Pilnackova B; Institute of Health Economics and Technology Assessment, Prague, Czech Republic., Dolezal T; Institute of Health Economics and Technology Assessment, Prague, Czech Republic.; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Publikováno v: Expert review of gastroenterology & hepatology [Expert Rev Gastroenterol Hepatol] 2023 Jan; Vol. 17 (1), pp. 99-108. Date of Electronic Publication: 2022 Dec 22.

PCR186 The Life With Cystic Fibrosis: Socioeconomic Impact of the Disease on Patients and Their Caregivers in the Czech Republic

Autor: Mlcoch, T, Velackova, B, Doleckova, K, Koznarova, B, Zabranska, S, Pilnackova, B, Decker, B, Tužil, J, Blazkova, T, Dolezalova, H, Doležal, T

Publikováno v: In Value in Health December 2022 25(12) Supplement:S426-S426

Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry.

Autor: Kojanova M; Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic., Hugo J; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic., Velackova B; Value Outcomes, Prague, Czech Republic., Cetkovska P; Department of Dermatovenereology, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic., Fialova J; Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic., Dolezal T; Value Outcomes, Prague, Czech Republic., Tichy M; Department of Dermatology and Venereology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Olomouc, Czech Republic., Gkalpakiotis S; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.

Publikováno v: The Journal of dermatological treatment [J Dermatolog Treat] 2022 Sep; Vol. 33 (6), pp. 2827-2837. Date of Electronic Publication: 2022 May 29.

Management of moderate to severe psoriasis with brodalumab-Real-world evidence from the LIBERO study.

Autor: von Kiedrowski R; Medical Study & Service Selters GmbH, Selters (Westerwald), Germany., Hinz T; Zentrum für Hautgesundheit, Neuwied, Germany., Mauer G; Hautarztpraxis, Bad Kreuznach, Germany., Schwinn A; Hautarztpraxis, Memmingen, Germany., Timmel A; Hautzentrum Rügen, Bergen, Germany., Hutt HJ; LEO Pharma GmbH, Neu-Isenburg, Germany., Augustin M; German Center for Health Services Research in Dermatology (CVderm), Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Nov; Vol. 38 (11), pp. 2156-2166. Date of Electronic Publication: 2024 Apr 04.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.